Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedApr 27, 2022ARA-290Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding · D-0775-2022Class IITerminatedApr 27, 2022Rifampin for InjectionFailed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.Mylan Pharmaceuticals Inc · D-0774-2022Class IITerminatedApr 27, 2022Diclofenac Sodium Topical Solution 1.5% w/wCGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.Preferred Pharmaceuticals, Inc. · D-0773-2022Class IITerminatedApr 20, 2022Econazole Nitrate CreamCGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc.is discontinuing its stability study program.Preferred Pharmaceuticals, Inc. · D-0771-2022Class IITerminatedApr 20, 2022Preferred PharmaceuticalsOut of specification results observed in dissolution during long term stability testing.Preferred Pharmaceuticals, Inc. · D-0769-2022Class IITerminatedApr 20, 2022Clobetasol Propionate Lotion 0.05%CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.Preferred Pharmaceuticals, Inc. · D-0768-2022Class IIITerminatedApr 20, 2022Cyanocobalamin InjectionSubpotent Drug: Out of Specification results for AssayAurobindo Pharma USA Inc. · D-0766-2022Class ITerminatedApr 20, 2022IDArubicin Hydrochloride Injection USP 5gm/5mLPresence of Particulate Matter: Product was found to contain silica and iron oxideTeva Pharmaceuticals USA Inc · D-0765-2022Class IIITerminatedApr 13, 2022Cequa (cyclosporine ophthalmic solution) 0.09%Subpotent Drug and Presence of Particulate Matter: low out-of-specification results obtained for assay and the presence of particulate matter.Sun Pharmaceutical Industries Inc · D-0770-2022Class ITerminatedApr 13, 2022SYMJEPIDefective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.Adamis Pharmaceuticals Corporation · D-0764-2022Class ITerminatedApr 13, 2022SYMJEPIDefective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.Adamis Pharmaceuticals Corporation · D-0763-2022Class IIITerminatedApr 13, 2022Risedronate Sodium TabletsFAILED CONTENT UNIFORMITY SPECIFICATIONSMacleods Pharma Usa Inc · D-0762-2022Class IITerminatedApr 13, 2022AccureticCGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.Pfizer Inc. · D-0761-2022Class IITerminatedApr 13, 2022quinapril HCl/hydrochlorothiazide tabletsCGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.Pfizer Inc. · D-0760-2022Class IITerminatedApr 13, 2022quinapril HCl/hydrochlorothiazide tabletsCGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.Pfizer Inc. · D-0759-2022Class IITerminatedApr 13, 2022quinapril and hydrochlorothiazide tabletsCGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.Pfizer Inc. · D-0758-2022Class IITerminatedApr 13, 2022AccureticCGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.Pfizer Inc. · D-0757-2022Class IITerminatedApr 13, 2022AccureticCGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.Pfizer Inc. · D-0756-2022Class IITerminatedApr 13, 2022AccureticCGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.Pfizer Inc. · D-0755-2022Class IITerminatedApr 13, 2022AccureticCGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.Pfizer Inc. · D-0754-2022Class IITerminatedApr 13, 2022Orphenadrine Citrate Extended-Release TabletsCGMP Deviations:Nitrosamine impurity (NMOA) above the acceptable daily limit.Sandoz, Inc · D-0753-2022Class IIITerminatedApr 13, 2022Methylprednisolone TabletsSubpotentJubilant Cadista Pharmaceuticals, Inc. · D-0752-2022Class IITerminatedApr 13, 2022The Natural Dentist Healthy Breath Antiseptic RinseLabeling; Label mix-up and Wrong Bar Code; back label incorrectly states active ingredient as Peppermint Oil and Sage Oil and has the wrong UPCRevive Personal Products Company · D-0751-2022Class IITerminatedApr 13, 2022Sucralfate Oral SuspensionLabeling: Label Mix-UpDASH Pharmaceuticals LLC · D-0749-2022Class IITerminatedApr 13, 2022Travoprost Ophthalmic SolutionSubpotent Drug and Failed Impurities/Degradation Specifications: low out-of-specification results obtained for assay and high out-of-specification results for related...Mylan Pharmaceuticals Inc · D-0748-2022Class IIITerminatedApr 13, 2022NETSPOTSubpotent Drug: low out-of-specification results for Vial 1 assay obtained during stability studies.Advanced Accelerator Applications USA, Inc. · D-0747-2022Class IITerminatedApr 13, 2022JanumetPresence of foreign substance: Presence of stainless steel particulates in tablets.Merck Sharp & Dohme Corp · D-0746-2022Class IIITerminatedApr 13, 202223.4% Sodium Chloride InjectionLabeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection...The Ritedose Corporation · D-0745-2022Class IITerminatedApr 13, 2022PHENOBARBITAL Sodium InjectionLack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.Vitae Enim Vitae Scientific, Inc. · D-0744-2022Class IITerminatedApr 13, 2022PHENOBARBITAL Sodium InjectionLack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.Vitae Enim Vitae Scientific, Inc. · D-0743-2022Class IITerminatedApr 13, 2022PAPAVERINE HYDROCHLORIDE InjectionLack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.Vitae Enim Vitae Scientific, Inc. · D-0742-2022Class IITerminatedApr 13, 2022TETRACAINE 1% Tetracaine HCI InjectionLack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.Vitae Enim Vitae Scientific, Inc. · D-0741-2022Class ITerminatedApr 6, 2022Meclizine Hydrochloride Tablets USPLabeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE...Jubilant Cadista Pharmaceuticals, Inc. · D-0767-2022Class IITerminatedApr 6, 2022Lansoprazole Delayed-Release CapsulesFailed Dissolution Specifications; during long term stability testing.Dr. Reddy's Laboratories, Inc. · D-0738-2022Class IITerminatedApr 6, 2022Lansoprazole Delayed-Release CapsulesFailed Dissolution Specifications; during long term stability testing.Dr. Reddy's Laboratories, Inc. · D-0737-2022Class IITerminatedApr 6, 2022Glycopyrrolate TabletsPresence of Foreign Substance: Complaint for pieces of glass discovered in a sealed bottle which came from equipment within the packaging room.Aurolife Pharma, LLC · D-0736-2022Class IITerminatedApr 6, 2022TESTOSTERONE CYPIONATE *GS*Lack of sterility assurance.Drug Depot, Inc., dba APS Pharmacy · D-0735-2022Class IITerminatedApr 6, 2022TESTOSTERONE CYPIONATE *GS* Oil 200 MG/ML InjectableLack of sterility assurance.Drug Depot, Inc., dba APS Pharmacy · D-0734-2022Class IITerminatedApr 6, 2022TESTOSTERONE CYPIONATE/PROPIONATE *SES* OilLack of sterility assurance.Drug Depot, Inc., dba APS Pharmacy · D-0733-2022Class IITerminatedApr 6, 2022TESTOSTERONE CYPIONATE/ DHEA *GS* 200/10MG/ML InjectableLack of sterility assurance.Drug Depot, Inc., dba APS Pharmacy · D-0732-2022

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.